pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

20,588 catalysts · 4,728 grant · 3,706 8k filing · 2,986 device 510k · 2,765 approval · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 6 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-05-14×clear all
type
  • grant4,728
  • 8k filing3,706
  • device 510k2,986
  • approval2,765
  • device pma2,000
  • device recall2,000
  • device adverse event1,000
  • recall738
  • earnings585
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 13, 2026

    50
    ›Apr 15, 2026recall143d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall143d agoFagron Compounding Services recall (Cls II)Revalesio Corp

    Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall143d agoGE Healthcare Ireland Limited recall (Cls II)Amneal Pharmaceuticals, Inc.

    GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. — Reason: Presence of particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall143d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall143d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall143d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026drug shortage143d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoSodium Acetate Injection shortage — Milla PharmaceuticalsMilla Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoClonazepam Tablet shortage — Cheplapharm Arzneimittel GmbHCHEPLAPHARM Arzneimittel GmbH

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoMethotrexate Sodium Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoLisdexamfetamine Dimesylate Capsule shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Capsule

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoMidazolam Hydrochloride Injection shortage — Avet Pharmaceuticals, Inc.AVEO Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoAtropine Sulfate Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoClonazepam Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Sunrise Pharmaceutical, Inc.Sunrise Pharmaceutical Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoTiagabine Hydrochloride Tablet shortage — Teva Pharmaceuticals USA, Inc.Teva Pharmaceuticals USA Inc

    Status: To Be Discontinued. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoQuinapril/Hydrochlorothiazide Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoCarboplatin Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoClonazepam Tablet shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoFurosemide Injection shortage — Avet Pharmaceuticals, Inc.AVEO Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoBumetanide Injection shortage — MSN Laboratories Private LimitedEdenbridge Pharmaceuticals LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoAtropine Sulfate Injection shortage — American Regent, Inc.American Regent Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoQuinapril Hydrochloride Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoSodium Bicarbonate Injection shortage — Exela Pharma Sciences, LLCExela Pharma Sciences LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoSterile Water Injection shortage — Medefil, Inc.Medefil Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoAtropine Sulfate Injection shortage — Medefil, Inc.Medefil Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage143d agoTechnetium TC-99M Pyrophosphate Kit Injection shortage — Curium US LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026grant143d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Project 4New York University

    AI grant. $344,099. PI: Vasishta Tatapudi

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoPENNSYLVANIA STATE UNIVERSITY, THE — Project 2: Infrastructure Development

    AG grant. $542,766. PI: Martin J Sliwinski

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoMONTANA STATE UNIVERSITY - BOZEMAN — Defining Staphylococcus aureus SaeR/S-mediated mechanisms that Impact Human N...

    GM grant. $211,579. PI: Madison Martin Collins

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — Street PrEP: Expanding a Low-Barrier PrEP Delivery Model Among People Who Use...

    DA grant. $588,669. PI: Albert Ying-Hwa Liu

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoMASSACHUSETTS GENERAL HOSPITAL — Optimizing High-Resolution MRI for Analyzing Perivascular Space Dynamics and ...Massachusetts General Hospital

    AG grant. $670,530. PI: Xiaoqing Alice Zhou

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — Is restrictive eating behavior in anorexia nervosa short-sighted? An experime...

    MH grant. $450,175. PI: Emily Caitlin Lloyd

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF CHICAGO — Natural variation of embryo development across the insect order of flies

    GM grant. $480,083. PI: URS C Schmidt-Ott

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoSTANFORD UNIVERSITY — T cell Contributions to Neointima Formation in Pulmonary HypertensionStanford University

    HL grant. $165,888. PI: Adam Michael Andruska

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoMIAMI UNIVERSITY OXFORD — FOXE3 in Creating Lens Chromatin Architecture and Transcriptional Identity

    EY grant. $467,969. PI: MICHAEL L ROBINSON

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF WASHINGTON — Optimizing Mindfulness Practice for Pain in People with Multiple SclerosisUniversity of Washington

    AT grant. $164,268. PI: Erin G. Mistretta

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Gathering Evidence for Patient-Informed Clinical Care of Early Female Puberty

    HD grant. $172,623. PI: Camilia Kamoun

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF PENNSYLVANIA — 3D MRI Method for CMRO2 Mapping of the Brain in DementiaUniversity of Pennsylvania

    AG grant. $429,498. PI: Felix W Wehrli

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF PENNSYLVANIA — The Maternal Immune Axis Programs Fetal CorticogenesisUniversity of Pennsylvania

    MH grant. $689,249. PI: Yeong Shin Yim

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF CHICAGO — Investigating the Impact of Adolescent Social Experiences on Neurodevelopment...

    DA grant. $1,010,328. PI: Stephanie Mary Groman

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoSLOAN-KETTERING INST CAN RESEARCH — Investigating histone glycation as a new dynamic epigenetic mark

    GM grant. $528,000. PI: Yael E David-Shternberg

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE — Neurotensin 1 allosteric modulator for the treatment of pain

    NS grant. $3,855,681. PI: RU-RONG JI

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoWEILL MEDICAL COLL OF CORNELL UNIV — Adaptable and hemodynamic Gut-On-VascularNet models to mitigate radiation injury

    AI grant. $608,000. PI: Chandan Guha

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoGORDON RESEARCH CONFERENCES — 2026 Proteoglycans Gordon Research Conference and Seminar

    AR grant. $33,834. PI: JIAN LIU

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoCLEVELAND CLINIC LERNER COM-CWRU — Mechanobiology of Bruch’s membrane during aging: Implications for age-related...

    EY grant. $615,928. PI: BELA ANAND-APTE

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoMASSACHUSETTS GENERAL HOSPITAL — GPAT2 REGULATES MINERAL METABOLISM IN KIDNEY DISEASEMassachusetts General Hospital

    DK grant. $622,959. PI: Petra Simic

    full page →nih reporter ↗
    ›Apr 15, 2026grant143d agoUNIVERSITY OF KANSAS LAWRENCE — Bet you can't eat just one: Testing the abuse liability of hyper-palatable foods

    DA grant. $643,776. PI: Tera L Fazzino

    full page →nih reporter ↗
    ← prev
    page 323 of 412
    next →
    $TERN52.95-0.03%
    $AMRX17.87-1.05%
    $TERN52.95-0.03%